LSERS
ALNY icon

Louisiana State Employees Retirement System’s Alnylam Pharmaceuticals ALNY Stock Holding History

Louisiana State Employees Retirement System’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.59M Sell
8,600
-100
-1% -$30.2K 0.04% 491
2026
Q1 		$2.88M Sell
8,700
-100
-1% -$34K 0.05% 353
2025
Q4 		$3.5M Buy
+8,800
New +$3.89M 0.06% 273

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Louisiana State Employees Retirement System's ALNY Position: Q2 2026 in Review

Louisiana State Employees Retirement System reduced its Alnylam Pharmaceuticals (ALNY) stake by 1.1% in Q2 2026, selling an estimated $30.2K and leaving 8,600 shares worth $2.59M. The position accounts for 0.04% of the portfolio, ranked #491.

Louisiana State Employees Retirement System first reported a position in ALNY in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.5M in Q4 2025. 791 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Louisiana State Employees Retirement System held 8,600 shares of Alnylam Pharmaceuticals worth $2.59M as of Q2 2026.
  • Louisiana State Employees Retirement System sold 100 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $30.2K.
  • Alnylam Pharmaceuticals made up 0.04% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #491 holding.
  • Louisiana State Employees Retirement System first reported a position in Alnylam Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Louisiana State Employees Retirement System's Alnylam Pharmaceuticals position peaked at $3.5M in Q4 2025.
  • 791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.